Role of reactive oxygen species in dermatologic diseases

Clinics in Dermatology

Volumn 14, Issue 4, 1996, Pages 343-352

  Boh, Erin E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE;

ACNE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AUTOIMMUNITY; DRUG HYPERSENSITIVITY; IMMUNOPATHOLOGY; LEUKOCYTOCLASTIC VASCULITIS; OXIDATIVE STRESS; PHOTODERMATOSIS; PHOTOSENSITIVITY; PORPHYRIA; PRIORITY JOURNAL; REVIEW; ROSACEA; SKIN DISEASE;

EID: 0030575335     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00064-8     Document Type: Article

References (53)

1. 1. Fridovich I. The biology of oxygen radicals. Science 1978; 209:875-80.
2. 2. Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide by iron. Proc R Soc London A 1934;147:332-51.
3. 3. Trefzer U, Brockhaus M, Loetscher H, et al. The 55-kd tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest 1993;92:462-470.
4. 4. Halliwell B. Reactive oxygen species in pathology with special reference to the skin. In: Fuchs J, Packer L, editors. Oxidative stress in dermatology. New York: Marcel Dekker, 1993;3-11.
5. 5. Soter NA. Acute effects of ultraviolet radiation on the skin. Semin Dermatol 1990;9:11-15.
6. 6. Hruza LL, Pentland AP. Mechanisms of UV-induced inflammation. J Invest Dermatol 1993;100:35s-41s.
7. 7. Miyachi Y, Horio T, Imamura S. Sunburn cell formation is prevented by scavenging oxygen intermediates. Clin Exp Dermatol 1983;83:166-8.
8. 8. Danno K, Horio T, Takigawa M, Imamura S. Role of oxygen intermediates in UV-induced epidermal cell injury. J Invest Dermatol 1984;83:166-8.
9. 9. Miyachi Y. Skin diseases associated with oxidative injury. In: Fuchs J, Packer L, editors. Oxidative stress in dermatology. New York: Marcel Dekker, 1993;323-31.
10. 10. Krutmann J, Grewe M. Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 1995;105:67s-70s.
11. 2, and 6-oxo-Fla, and histamine in human skin following UVA irradiation. J Invest Dermatol 1983;80:496-9.
12. 12. Norris DA, Lyons MB, Middleton MH, Yohn JJ, Kashihara-Sawami M. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule-1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol 1990;95:132-8.
13. 13. Gougerot-Pocidalo M, Revillard J. Oxidative stress, cytokines, and lymphocyte activation. In: Fuchs J, Packer L, editors. Oxidative stress in dermatology. New York: Marcel Dekker, 1993;187-205.
14. 14. Miyachi Y, Imamura S, Niwa Y, et al. Mechanisms of contact photosensitivity in mice. VI. Oxygen intermediates are involved in contact photosensitization but not in ordinary contact sensitization. J Invest Dermatol 1986;8: 26-8.
15. 15. Schmidt RJ, Kuhn L, Chung LY. Are free radicals and not quinones the haptenic species derived from uroshiols and other contact allergenic mono-and dihydric alkylbenzenes? The significance of NADH, glutathione, and redox cycling in the skin. Arch Dermatol Res 1990;282:56-64.
16. 16. Sharkey P, Eey DJ, Burrows D, et al. A possible role for superoxide production in the pathogenesis of contact dermatitis. Acta Derm Venereol (Stockh) 1991;71:156-9.
17. 17. Hayakawa K, Matsuo I, Fujita H, et al. Thiazide phototoxicity: Evidence for participation of singlet oxygen in photohemolysis. In: Fuchs J, Packer L, editors. Oxidative stress in dermatology. New York: Marcel Dekker, 1993;101-6.
18. 18. Pathak M, Carraro C. Reactive oxygen species in cutaneous photosensitivity reactions in porphyrias and PUVA photochemotherapy and in melanin pigmentation. In: Hayaishi O, Imamura S, Miyachi Y, editors. The biological role of reactive oxygen species in skin. New York: Elsevier, 1987;75-94.
19. 19. Kochevar IE. Mechanisms of phototoxicity for nonsteroidal anti-inflammatory drugs. In: Urbach F, editor. Biological responses to ultraviolet radiation. Kansas: Valdenmar, Overland Park, 1992;101-6.
20. 20. Miyachi Y. Reactive oxygen species in photodermatology. In: Fuchs J, Packer L, editors. Oxidative stress in dermatology. New York: Marcel Dekker, 1993;37-41.
21. 21. Pathak MA. Mechanism of psoralen photosensitization reactions. Natl Cancer Monog 1984;66:41-6.
22. 22. Blan QA, Grossweiner LI. Singlet oxygen generation by furocoumadins: Effect of DNA and liposomes. Photochem Photobiol 1987;45:177-83.
23. 23. Potapenko AY. New trends in photobiology: Mechanisms of photodynamic effects of furocoumadins. J Photochem Photobiol 1991;9:1-33.
24. -) by psoralens and ultraviolet radiation (320-400 nm). Biochim Biophys Acta 1984;798:115-26.
25. 25. Foote CS. Mechanisms of photooxidized oxidation. Science 1968;162:963-70.
26. 26. Menon IA, Persad S, Haberman HF. A comparison of the phototoxicity of protoporhyrin, coproporphyrin, and uroporphyrin using a cellular system in vitro. Clin Biochem 1989;22:197-200.
27. 27. Johnston RB, Lehmeyer JE. Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest 1976;57:836-41.
28. 28. Shingu M, Todoroki T, Nobunaga M. Generation of superoxide by immunologically stimulated normal human neutrophils and possible modulation by intracellular and extracellular SOD and rheumatoid factor. Inflammation 1987;11:143-51.
29. 29. Emerit I, Michelson AM. Mechanism of photosensitivity in systemic lupus erythematosus patients. Proc Natl Acad Sci USA 1981;78:2537-40.
30. 30. Niwa Y, Sakane T, Shingu M, et al. Role of stimulated neutrophils from patients with systemic lupus erythematosus in tissue injury, with special reference to serum factors and increased active oxygen species generated by neutrophils. Inflammation 1985;9:163-72.
31. 31. Abramson SB, Given WP, Edelson HS, et al. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus. Arthritis Rheum 1983;26: 630-6.
32. 32. Hashimoto YM, Ziff M, Hurd ER. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera. Arthritis Rheum 1982;25: 1409-18.
33. 33. Michelson AM. Oxygen radicals. Agents actions 1982; 11(Suppl):179-201.
34. 34. Murrell DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 1993;28:78-85.
35. 35. Kilbourne EM, Rigau-Perez JG, Heath CW, et al. Clinical epidemiology of toxic-oil syndrome: Manifestations of a new illness. N Engl J Med 1983;309:1408-14.
36. 36. Finch WR, Rodnan GP, Buckingham RB, et al. Bleomycin-induced scleroderma. J Rheumatol 1980;7:651-9.
37. 37. Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 1989;111:377-83.
38. 38. Connolly SM, Quimby SR, Griffing WL, et al. Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome. J Am Acad Dermatol 1990;29: 289-98.
39. 39. Doelman CJ, Bast A. Oxygen radicals in lung pathology. Free Radic Biol Med 1990;9(suppl 1):387-400.
40. 40. Sedgwick JB, Bergstresser PR, Hurd ER. Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol 1980;76:158-63.
41. 41. Sedgwick JB, Bergstresser PR, Hurd ER. Increased superoxide generation by normal granulocytes incubated in sera from patients with psoriasis. J Invest Dermatol 1981; 76:158-63.
42. 42. Miyachi Y, Niwa Y. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leukocytes. Arch Dermatol Res 1983;275:23-6.
43. 43. Yoshioka A, Miyachi Y, Imamura S, et al. Anti-oxidant effects of retinoids on inflammatory skin diseases. Arch Dermatol Res 1986;278:177-83.
44. 44. Miyachi Y, Yoshioka A, Imamura S, et al. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 1987;28:190-5.
45. 45. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine, and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 1982;107:209-14.
46. 46. Miyachi Y, Imamura S, Niwa Y. Erythema multiforme: A possible role of increased reactive oxygen species. J Clin Lab Immunol 1986;19:11-4.
47. 47. Miyachi Y, Taniguchi S, Ozaki M, et al. Colchicine in the treatment of the cutaneous manifestations of Behcet's disease. B J Dermatol 1981;104:67-9.
48. 48. Niwa Y, Sakane T, Shingu M, et al. Neutrophil-generated active oxygens in linear IgA bullous dermatosis. Arch Dermatol 1985;121:73-8.
49. 49. Hegemann L, Toso SM, Kitay K, et al. Anti-inflammatory actions of benzoyl peroxide: Effects on the generation of reactive oxygen species by leukocytes and the activity of protein kinase C and calmodulin. Br J Dermatol 1994;130:569-75.
50. 50. Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986;86:449-53.
51. 51. Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 1986;114:231-4.
52. 52. Maly F, The B lymphocyte: A newly recognized source of reactive oxygen species with immunoregulatory potential. Free Radic Res Commun 1990;8:143-8.
53. 53. Halliwell B, Cross C, Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Arch Intern Med 1991;151;29-31.